Search Results - "Byakhov, Mikhail J." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

by Gianni, Luca, Dr, Eiermann, Wolfgang, MD, Semiglazov, Vladimir, MD, Lluch, Ana, PhD, Tjulandin, Sergei, MD, Zambetti, Milvia, MD, Moliterni, Angela, MD, Vazquez, Federico, MD, Byakhov, Mikhail J, PhD, Lichinitser, Mikhail, MD, Climent, Miguel Angel, MD, Ciruelos, Eva, MD, Ojeda, Belen, MD, Mansutti, Mauro, MD, Bozhok, Alla, PhD, Magazzù, Domenico, PhD, Heinzmann, Dominik, PhD, Steinseifer, Jutta, PhD, Valagussa, Pinuccia, BS, Baselga, Jose, MD
Published in The lancet oncology (01.05.2014)

Get full text

Journal Article

Follow-up results of NOAH, a randomized phase III trial evaluating neoadjuvant chemotherapy with trastuzumab (CT+H) followed by adjuvant H versus CT alone, in patients with HER2-positive locally advanced breast cancer

Follow-up results of NOAH, a randomized phase III trial evaluating neoadjuvant chemotherapy with trastuzumab (CT+H) followed by adjuvant H versus CT alone, in patients with HER2-positive locally advanced breast cancer

by Gianni, Luca, Eiermann, Wolfgang, Semiglazov, Vladimir, Manikhas, Alexey, Lluch, Ana, Tjulandin, Sergei, Zambetti, Milvia, Vazquez, Federico, Byakhov, Mikhail J., Lichinitser, Mikhail, Climent, Miguel Angel, Ciruelos, Eva, Ojeda, Belen, Mansutti, Mauro, Bozhok, Alla, Magazzu, Domenico, Steinseifer, Jutta, Valagussa, Pinuccia, Baselga, Jose
Published in Journal of clinical oncology (20.05.2013)

Get full text

Journal Article

Freedom from progression (FFP) by adding paclitaxel (T) to doxorubicin (A) followed by CMF as adjuvant or primary systemic therapy: 10-yr results of a randomized phase III European Cooperative Trial in Operable Breast Cancer (ECTO)

Freedom from progression (FFP) by adding paclitaxel (T) to doxorubicin (A) followed by CMF as adjuvant or primary systemic therapy: 10-yr results of a randomized phase III European Cooperative Trial in Operable Breast Cancer (ECTO)

by Zambetti, Milvia, Baselga, José, Eiermann, Wolfgang, Guillem, Vicente, Semiglazov, Vladimir, Lluch, Ana, Sabadell, Dolores, Bozhok, Alla, Byakhov, Mikhail J., Ojeda, Belen, Mansutti, Mauro, Mariani, Gabriella, Moliterni, Angela, Cortes-Funes, Hernan, Colozza, Marian, Pienkowski, Tadeusz, Magazzu, Domenico, Valagussa, Pinuccia, Bonadonna, Gianni, Gianni, Luca
Published in Journal of clinical oncology (20.05.2013)

Get full text

Journal Article